2563 — Beijing Biostar Pharmaceuticals Co Balance Sheet
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeSmall Cap
- HK$1.61bn
- HK$1.61bn
- CNY66.64m
Annual balance sheet for Beijing Biostar Pharmaceuticals Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | HKAS | HKAS |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Short Term Investments | ||
| Cash and Short Term Investments | 729 | 576 |
| Net Total Accounts Receivable | ||
| Net Total Receivables | 39 | 15.9 |
| Total Inventory | ||
| Prepaid Expenses | ||
| Total Current Assets | 805 | 634 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 118 | 136 |
| Net Intangible Assets | ||
| Other Long Term Assets | ||
| Total Assets | 926 | 772 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Current Portion of Long Term Debt / Capital Leases | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 51.7 | 43.7 |
| Capital Lease Obligations | ||
| Total Long Term Debt | ||
| Total Debt | ||
| Total Other Liabilities | ||
| Total Liabilities | 58.4 | 49.2 |
| Common Stock | ||
| Retained Earnings (Accumulated Deficit) | ||
| Other Equity | ||
| Total Equity | 868 | 723 |
| Total Liabilities & Shareholders' Equity | 926 | 772 |
| Total Common Shares Outstanding |